Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Molecular and Cellular Endocrinology|March 1, 1988
Thyrotropin-releasing hormone-stimulated inositol trisphosphate formation is liable to thyrotropin-releasing hormone-induced desensitization by a calcium-dependent mechanismP A Torjesen, T Bjøro, B C Ostberg, et al.
Archives of Andrology|September 1, 1980
FSH-response adenylyl cyclase in rat testes: desensitization by homologous hormoneT Jahnsen, J O Gordeladze, P A Torjesen, et al.
Molecular and Cellular Endocrinology|April 1, 1991
Cholecalciferol metabolites attenuate cAMP production in rat thyroid cells (FRTL-5)J P Berg, G Sørnes, P A Torjesen, et al.
Thrombosis Research|November 15, 1996
Binding of tissue factor pathway inhibitor to cultured endothelial cells-influence of glycosaminoglycansN Iversen, P M Sandset, U Abildgaard, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetesK I Birkeland, K F Hanssen, P A Torjesen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 21, 2009
Biochemical characterization of four novel mutations in the thyroid hormone receptor beta gene in patients with resistance to thyroid hormoneA B Asadi, P A Torjesen, E Haug, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 1992
The lipoxygenase inhibitor nafazatrom inhibits stimulated prolactin secretion in cultured rat lactotrophs (GH4C1 cells)T Bjøro, V Larsen, K Englund, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 1, 1994
Long-term effects of n-3 fatty acids on serum lipids and glycaemic controlJ Eritsland, I Seljeflot, M Abdelnoor, et al.
Diabetes Care|November 1, 1994
Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemiaK I Birkeland, P A Torjesen, J Eriksson, et al.
Acta Endocrinologica|April 1, 1993
Different responses in little and bigbig prolactin to metoclopramide in subjects with hyperprolactinemia due to 150-170 kD (bigbig) prolactinT Bjøro, E Johansen, H H Frey, et al.
Pageof 7